ALEMBIC PHARMACEUTICALS
Back to Balance Sheet
|
ALEMBIC PHARMACEUTICALS Last 5 Year Net Current Assets History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹1,949 Cr | ₹1,675 Cr | ₹1,624 Cr | ₹1,273 Cr | ₹1,144 Cr |
What is the latest Net Current Assets ratio of ALEMBIC PHARMACEUTICALS ?
| Year | Net Current Assets |
|---|---|
| Mar2026 | ₹1,949 Cr |
| Mar2025 | ₹1,675 Cr |
| Mar2024 | ₹1,624 Cr |
| Mar2023 | ₹1,273 Cr |
| Mar2022 | ₹1,144 Cr |
How is Net Current Assets of ALEMBIC PHARMACEUTICALS Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2026 | ₹1,949 Cr | 16.31 | |
| Mar2025 | ₹1,675 Cr | 3.20 | |
| Mar2024 | ₹1,624 Cr | 27.53 | |
| Mar2023 | ₹1,273 Cr | 11.26 | |
| Mar2022 | ₹1,144 Cr | - | |
Compare Net Current Assets of peers of ALEMBIC PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ALEMBIC PHARMACEUTICALS | ₹20,516.2 Cr | 2% | 33.3% | 15.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹449,228.0 Cr | -1.4% | 6.3% | 7.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹293,874.0 Cr | -1.8% | 20.6% | 70.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹176,413.0 Cr | -1.9% | 2.4% | 22.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹116,604.0 Cr | 0.8% | 12.6% | 12.3% | Stock Analytics | |
| CIPLA | ₹114,720.0 Cr | -2.4% | 4.4% | -8.3% | Stock Analytics | |
ALEMBIC PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ALEMBIC PHARMACEUTICALS | 2% |
33.3% |
15.1% |
| SENSEX | 1.8% |
11.1% |
-1.6% |
You may also like the below Video Courses